$97.5MSeries A, 6 October 2025
First close funds NP-MP1 through IND-enabling studies and early clinical development.
- Amount
- $97.5M
- Stage
- Series A
- Announced
- 6 October 2025
- Lead
- XGEN Venture
- Other investors
- Sofinnova Partners, CDP Venture Capital, Panakes Partners
- Use of funds
- First close funds NP-MP1 through IND-enabling studies and early clinical development.
- Checked
- Announced by the company
- Sources
- NanoPhoria raises €84M Series A (amount in EUR as listed by tech.eu) sofinnovapartners.com
NanoPhoria raises €84M Series A (amount in EUR as listed by tech.eu) funding.tech.eu